Compare ONCY & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONCY | SUNS |
|---|---|---|
| Founded | 1998 | 2023 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.7M | 114.4M |
| IPO Year | 2002 | N/A |
| Metric | ONCY | SUNS |
|---|---|---|
| Price | $0.94 | $7.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $7.33 | ★ $8.75 |
| AVG Volume (30 Days) | ★ 1.6M | 137.6K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 16.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $70.81 |
| Revenue Next Year | $2,505.00 | N/A |
| P/E Ratio | ★ N/A | $8.84 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $7.34 |
| 52 Week High | $1.51 | $11.78 |
| Indicator | ONCY | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 37.53 |
| Support Level | $0.90 | $7.39 |
| Resistance Level | $1.06 | $8.18 |
| Average True Range (ATR) | 0.06 | 0.30 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 62.80 | 4.95 |
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.